IQVIA Holdings (IQV) reported $16.3B in revenue for fiscal 2025, +5.9% year on year. That ranks #340 by revenue among 2853 SEC filers and #38 in Healthcare. Net income was $1.4B, a net margin of 8.3%. Revenue has grown 9.9% a year on average since 2011 ($4.3B then). The fiscal 2025 balance sheet shows $29.9B in total assets, $2.0B in cash and $13.9B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $16.3B | +5.9% | FY20252025-12-31 |
| Gross profit | Not reported | — | |
| Operating incomeOperatingIncomeLoss | $2.2B | −0.9% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $1.4B | −0.9% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $2.7B | −2.3% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquireProductiveAssets | $603M | +0.2% | FY20252025-12-31 |
| Total assetsAssets | $29.9B | +11.3% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $6.5B | +7.2% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $2.0B | +16.3% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $13.9B | +8.1% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $4.2B | $274M | Open → |
| Q2 20262026-06-30 | $4.4B | $256M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 68 of 161 companies compared | 8.3% | |
| Operating marginRank 62 of 160 companies compared | 13.4% | |
| R&D as share of revenueRank 102 of 102 companies compared | 0.0% | |
| Cash as share of revenueRank 76 of 160 companies compared | 12.1% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- IQVIA Holdings Inc.
- Ticker
- IQV
- Exchange
- NYSE
- SIC classification
- Services-Commercial Physical & Biological Research (8731)
- Fiscal year end
- 12-31
- CIK
- 0001478242
Filings
- 10-QJul 28, 2026Open filing →
- 10-QMay 5, 2026Open filing →
- 10-KFeb 17, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Universal Health ServicesUHS | $17.4B | $1.5B |
| Teva Pharmaceutical IndustriesTEVA | $17.3B | $1.4B |
| AflacAFL | $17.2B | $3.6B |
| IQVIA HoldingsIQV | $16.3B | $1.4B |
| Principal FinancialPFG | $15.6B | $1.3B |
| Regeneron PharmaceuticalsREGN | $14.3B | $4.5B |
| ViatrisVTRS | $14.3B | −$3.5B |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=IQVIA Holdings — Key figures |url=https://companiesranked.com/en/company/iqvia-holdings |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). IQVIA Holdings — Key figures. CompaniesRanked. https://companiesranked.com/en/company/iqvia-holdingsBibTeX
@misc{companiesranked-en-company-iqvia-holdings-2026,
author = {{CompaniesRanked}},
title = {{IQVIA Holdings — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/iqvia-holdings}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-008322 · February 17, 2026
{{cite web |title=IQVIA Holdings — Key figures — 10-K (0001628280-26-008322) |url=https://www.sec.gov/Archives/edgar/data/1478242/000162828026008322/iqv-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.